15 results
424B5
EQ
Equillium Inc
5 Oct 23
Prospectus supplement for primary offering
5:23pm
supplement, the warrants and warrant agreements, and any claim, controversy or dispute arising under or related to the warrants or warrant agreements
425
EQ
Equillium Inc
6 Sep 22
Business combination disclosure
4:33pm
THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY
8-K
EX-2.1
EQ
Equillium Inc
6 Sep 22
Equillium to Acquire Metacrine in All-Stock Transaction
4:29pm
be permitted by Law, shall be valid and sufficient service thereof.
(b) EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER
424B5
y9337e9
4 Feb 21
Prospectus supplement for primary offering
8:07am
424B5
m97 prwrdu
14 Aug 20
Prospectus supplement for primary offering
4:45pm
424B5
bd5 hir4yz
13 Aug 20
Prospectus supplement for primary offering
4:04pm
424B5
5uzcif49jps70k4we1
14 Jul 20
Prospectus supplement for primary offering
6:05am
S-3
EX-4.7
xfbvv6 k630
13 Nov 19
Shelf registration
5:20pm
S-3
EX-4.9
9ufyyd 0ou47qst82kr
13 Nov 19
Shelf registration
5:20pm
S-3
gzyw86 tkdcatm51u3pn
13 Nov 19
Shelf registration
5:20pm
S-3
EX-4.8
c45yz gclky
13 Nov 19
Shelf registration
5:20pm
DRS
EX-10.7
yz41zj
3 Aug 18
Draft registration statement
12:00am
DRS
EX-10.6
lbf12q7 p0
3 Aug 18
Draft registration statement
12:00am
- Prev
- 1
- Next